Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Objective: The objective of this systematic review and meta-analysis was to evaluate the overall efficacy of cognitive behavioral therapy for insomnia (CBT-I) in treating insomnia in adolescents, and to examine the efficacy of CBT-I on different sleep-related outcomes in this population.
Methods: Randomized controlled trials (RCTs) of CBT-I on insomnia in adolescents were identified using electronic databases and manual searches. The Revised Cochrane risk-of-bias tool for randomized trials (RoB 2) was used to assess risk of bias in RCTs. A standardized mean difference (SMD) with a 95% confidence interval (CI) was used to combine effect sizes. A sensitivity analysis was performed for each outcome using a stepwise elimination method to assess whether the pooled results were significantly affected by individual studies.
Results: The analysis included 8 RCTs involving a total of 599 participants. The meta-analysis indicated that marked and statistically significant improvements in insomnia (SMD = -1.06; 95% CI -1.65 to -0.47; < 0.01), sleep onset latency (SMD = -0.99; 95% CI -1.65 to -0.32; < 0.01), total sleep time (SMD = 0.50; 95% CI 0.10 to 0.90; = 0.01), and sleep efficiency (SMD = 0.57; 95% CI 0.26 to 0.87; < 0.01) were observed at post-treatment time point following CBT-I. At follow-up time point, a statistically significant improvement in insomnia (SMD = -0.79; 95% CI -1.42 to -0.17; = 0.01) was observed following CBT-I.
Conclusion: CBT-I was effective in improving insomnia in adolescents and some sleep-related outcomes, including sleep onset latency, total sleep time, and sleep efficiency. CBT-I was characterized by low risk and high therapeutic benefits and could serve as alternative or adjuvant approaches to medication for the treatment of insomnia. Considering the advantages in terms of safety and efficacy, CBT-I should be the preferred intervention for the treatment of insomnia in adolescents.
Systematic Review Registration: https://www.crd.york.ac.uk/prospero/, CRD42024526102.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11613502 | PMC |
| http://dx.doi.org/10.3389/fpubh.2024.1413694 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Understanding discrepancies between self-reported and objective sleep in adolescents and young adults with subacute concussion.
Sleep Adv
July 2025
Department of Pediatrics, Division of Child Neurology, Doernbecher Children's Hospital, Oregon Health and Science University, Portland, OR, United States.
Study Objectives: Conduct a multidimensional analysis of sleep perception, objective sleep, and neuropsychiatric wellbeing in individuals with subacute concussion compared to controls.
Methods: Thirty-one recently concussed individuals completed the Pittsburgh Sleep Quality Index, Insomnia Severity Index, and Patient-Report Outcomes Measurement Information System measures of depression, anxiety, stress, and cognitive function. Concussion symptom severity scores (Sports Concussion Assessment Tool) were obtained from participants' health records.
Sleep disorder assessment in children and adolescents with neurodevelopmental disorders.
J Pediatr (Rio J)
September 2025
Escola de Medicina da Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, RS, Brazil; Instituto do Cérebro (InsCer), Porto Alegre, RS, Brazil. Electronic address:
Objective: To review the associations between various neurodevelopmental disorders and the most prevalent sleep disorders in children and adolescents, focusing on clinical characteristics and diagnostic approaches.
Data Sources: A literature review was conducted using the PubMed database, employing the search terms "neurodevelopmental disorders" and "sleep disorders," including "insomnia," "sleep-related breathing disorders," "circadian rhythm sleep-wake disorders," "sleep-related movement disorders," "parasomnias," and "central disorders of hypersomnolence." Specific diagnostic terms related to neurodevelopmental and sleep disorders were also utilized.
Benefits and challenges: Qualitative exploration of women's experiences during the COVID-19 pandemic in Fiji.
PLoS One
September 2025
Department of Public Health, College of Medicine, Nursing and Health Sciences, Fiji National University, Suva, Fiji.
The COVID-19 pandemic and its preventive strategies resulted in changes in economic, social and health activities globally, but the effects of these changes on women, have not been systematically studied and documented in Fiji. The current study explored the experiences of women during the COVID-19 pandemic in Fiji, using a qualitative approach with a descriptive phenomenological design. A total of 110 women were purposively selected across various age groups, ethnicity, religion and different settings to improve the study area diversity.
View Article and Find Full Text PDF[Guidelines for the diagnosis and treatment of insomnia disorder (2025 edition)].
Zhonghua Yi Xue Za Zhi
September 2025
Insomnia disorder is a common sleep disturbance, primarily characterized by difficulties in sleep initiation, sleep maintenance, or early morning awakening, accompanied by impaired daytime functioning. Since the publication of the in 2017, classifications and diagnostic criteria for insomnia have evolved, and clinical management protocols have been continuously updated, necessitating guideline revisions to better inform clinical practice. Therefore, the Chinese Sleep Research Society organized domestic experts in relevant fields to develop the following established clinical practice guideline development methodology.
View Article and Find Full Text PDFEfficacy and Acceptability of Licensed and Off-Label Pharmacological Interventions for Insomnia in Patients With Severe Mental Illness: A Systematic Review and Meta-Analysis of Randomised Trials.
Acta Psychiatr Scand
September 2025
Psychosis Research Unit, Aarhus University Hospital-Psychiatry, Aarhus, Denmark.
Background: A wide range of drugs is used to alleviate insomnia symptoms in individuals with severe mental illness (SMI), including licensed drugs and sedating drugs prescribed off-label. Yet, no review has gathered the evidence on illness-specific or transdiagnostic outcomes of pharmacological interventions for insomnia. We aimed to perform a systematic review and meta-analysis of randomised controlled trials (RCTs) studying the efficacy and acceptability of pharmacological interventions for insomnia among individuals with SMI, defined as schizophrenia, bipolar disorder (BD) or major depressive disorder (MDD).
View Article and Find Full Text PDF